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Background: Zero-mode waveguides (ZMWs) are photonic nanostructures that create highly confined optical
observation volumes, thereby allowing single-molecule-resolved biophysical studies at relatively high concentrations
of fluorescent molecules. This principle has been successfully applied in single-molecule, real-time (SMRTW) DNA
sequencing for the detection of DNA sequences and DNA base modifications. In contrast, RNA sequencing
methods cannot provide sequence and RNA base modifications concurrently as they rely on complementary DNA
(cDNA) synthesis by reverse transcription followed by sequencing of cDNA. Thus, information on RNA modifications
is lost during the process of cDNA synthesis.
Results: Here we describe an application of SMRT technology to follow the activity of reverse transcriptase
enzymes synthesizing cDNA on thousands of single RNA templates simultaneously in real time with single
nucleotide turnover resolution using arrays of ZMWs. This method thereby obtains information from the RNA
template directly. The analysis of the kinetics of the reverse transcriptase can be used to identify RNA base
modifications, shown by example for N6-methyladenine (m6A) in oligonucleotides and in a specific mRNA extracted
from total cellular mRNA. Furthermore, the real-time reverse transcriptase dynamics informs about RNA secondary
structure and its rearrangements, as demonstrated on a ribosomal RNA and an mRNA template.
Conclusions: Our results highlight the feasibility of studying RNA modifications and RNA structural rearrangements
in ZMWs in real time. In addition, they suggest that technology can be developed for direct RNA sequencing
provided that the reverse transcriptase is optimized to resolve homonucleotide stretches in RNA.Background
The function and dynamic regulation of all forms of
RNA are critically dependent on their sequence, struc-
ture, and post-transcriptional modifications [1]. Many
different methods have been developed to interrogate
RNA, but each tends to be sensitive to only one of these
characteristics. For example, standard sequencing of
RNA requires conversion into cDNA which causes the
loss of information about structure and certain base
modifications. In addition, these bulk methods average
over a large ensemble of RNA molecules, thereby leaving
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reproduction in any medium, provided the orunresolved. With the advent of single-molecule tech-
niques, it has become possible to sequence individual
molecules of RNA directly by adaptation of a short-read
DNA sequencing method to reverse transcription [2],
however this method is still insensitive to RNA modifi-
cations and structure.
We set out to adapt a technique originally developed
for single-molecule, real-time (SMRT) DNA sequencing
towards utilizing an HIV reverse transcriptase (HIV RT)
for concurrent determination of RNA sequence, base
modifications, and structure. Analogous to SMRT DNA
sequencing [3], the RT activity is visualized by
phospholinked deoxyribonucleotides that carry the
fluorophore attached to the terminal phosphate moiety
(Figure 1a). This allows for a continuous detection of
cDNA synthesis in real time, as the fluorescent label istd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Single-molecule, real-time (SMRT) reverse transcription in zero-mode waveguides (ZMWs). (a) Schematic of the SMRT reverse
transcription process. The RNA template (purple) is hybridized to a biotinylated DNA primer (orange) and immobilized at the ZMW bottom (I).
Reverse transcriptase (RT, gray) binds to the immobilized hybrid (II). Upon initiation of reverse transcription, a correctly base-paired phospholinked
nucleotide binds in the enzyme’s active site (III). The bound nucleotide can either dissociate from the complex (reverse reaction), or become
incorporated into the growing DNA chain, accompanied by the release of the labeled pyrophosphate (IV). HIV RT then translocates to the next
position and the reaction cycle (II) through (IV) repeats. (b) Hybrid for demonstrating SMRT reverse transcription, showing the RNA template
(purple), DNA primer (orange), and resulting DNA (base-specific color-coding). (c) Example trace of SMRT reverse transcription. Fluorescence
pulses are color-coded as in (b). Each block of pulses belonging to the same nucleotide is indicated above the trace. The gray block at the end
of the trace likely corresponds to non-templated cognate sampling. (d-e) Magnified views of the beginning and end of the trace, respectively.
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ation. Single RNA molecules are immobilized via a
biotinylated primer inside zero-mode waveguides
(ZMWs), and are independently and asynchronously in-
terrogated on arrays containing thousands of ZMWs.
The wild type HIV RT used in this study does not enable
the resolution of the homonucleotide stretches. Neverthe-
less, by analyzing the kinetics of HIV RT we demonstrate
the ability to detect base modifications in the RNA tem-
plate, as well as obtain information on RNA secondary
structure and its rearrangements. We also find that by fol-
lowing single-molecule reverse transcription in real time,it is possible to obtain sequence information from the
RNA template directly.
Results and discussion
Single-molecule real-time reverse transcription of RNA
A development of direct SMRT RNA sequencing re-
quires a processive RNA-dependent polymerase that can
utilize phospholinked nucleotides. Reverse transcriptases
represent one such class of enzymes which initiate
polymerization on a DNA-primed RNA template and
synthesize a complementary DNA strand. We evaluated
an in-house HIV, and commercially available AMV as
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phospholinked nucleotides during first strand synthesis.
A FAM-labeled DNA primer (FAM-P5) was hybridized
to a synthetic RNA template (Additional file 1: Table S1)
followed by the addition of RT with either native nucleo-
tides or phospholinked nucleotides (Additional file 1:
Figure S1a). The reactions were stopped by the addition
of excess EDTA; the samples were denatured and run on
a denaturing polyacrylamide gel (Additional file 1: Figure
S1b). The fractions of templates utilized by the reverse
transcriptases were determined by comparing the inten-
sities of the band corresponding to the FAM-labeled
DNA primer in the negative control and the reverse
transcription reaction (Additional file 1: Figure S1b, c).
In addition, we determined the fraction of the templates
that yielded full-length first strand by comparing the in-
tensity of the full length product in the reverse tran-
scription to the intensity of FAM-labeled DNA primer in
the negative control. A comparison of the data reveals
that only HIV RT demonstrates an activity in the pres-
ence of phospholinked nucleotides that results in a de-
tectable full-length product. Moreover, HIV RT shows
comparable full-length activities in the presence of native
and phospholinked nucleotides, with ~80% activity relative
to the native dNTPs (Additional file 1: Figure 1b, c).
To demonstrate real-time detection of single-molecule
reverse transcription in ZMWs, we employed HIV RT in
conjunction with the synthetic RNA template containing
a sequence signature of five consecutive repeats of 5’-
CUGA-3’ at its 5’-end (Figure 1b). Upon addition of HIV
RT to primed RNA templates immobilized in ZMWs,
reverse transcription was detected by the appearance of
fluorescent pulses (Figure 1c, Additional file 1: Figure
S2). The color of the fluorescent pulses indicated an in-
corporation sequence comprising five repeated cycles of
‘TCAG’, matching the expected order of nucleotide in-
corporations on this RNA template. However, unlike
SMRT DNA sequencing in which we introduced compen-
satory mutations to the DNA polymerase to restore the
kinetics of phospholinked nucleotides to a single fluores-
cent pulse per each incorporation event [3], here multiple
fluorescence pulses of the same nucleotide type are ob-
served for each incorporation cycle (Figure 1d). Such
blocks of like pulses are indicative of repeated binding and
dissociation of correctly base-paired phospholinked nucle-
otides in the enzyme’s active site before eventual incorpor-
ation into the growing DNA chain. Pre-steady state kinetic
measurements using bulk methods confirmed this inter-
pretation, showing higher nucleotide dissociation rates
compared to incorporation rates (Additional file 1: Figure
S3, Additional file 1: Table S3). The succession of blocks
can be used to determine the sequence of this RNA tem-
plate, indicated by the color-coded delineation above
the example trace in Figure 1c. While the groups offluorescent signals for each incorporation cycle increase the
confidence of RNA base calling, they currently preclude
the ability to accurately sequence RNAs containing
homonucleotide stretches. The incorporation time for a
single nucleotide varied as a function of nucleotide
type, with average block durations for A, C, G, and T
phospholinked nucleotides 12 s, 20 s, 16 s, and 6 s, respect-
ively (Additional file 1: Figure S4).
Upon completion of reverse transcription of the RNA
template, fluorescence pulse activity ceased for the majority
of SMRT reverse transcription reactions (data not shown).
For some RNA molecules, more random phospholinked
nucleotide binding events continued beyond this expected
termination point (Figure 1e, Additional file 1: Figure S2),
potentially reflecting non-templated extension at the
end of first DNA strand synthesis previously reported
for HIV RT [4].
Detecting N6-methyladenine (m6A) modification in RNA
N6-methyladenine (m6A) is the most abundant modifica-
tion in mRNAs of multicellular organisms and is also
present in viral RNAs that replicate in the nucleus [5-7].
The proposed function of m6A in mRNA includes modula-
tions of mRNA stability, splicing, and export from the nu-
cleus. m6A modification has also been shown to confer
innate immune tolerance of transfected exogenous RNA
[8]. siRNA knockdown of the catalytic subunit of m6A
methyltransferase led to cell apoptosis [6]. Despite the bio-
logical significance of m6A modification in mRNA, to date
only one modification site is known in a specific mRNA
due to the extremely laborious biochemical assays for map-
ping m6A sites in mRNA [6]. Current RNA sequencing
methods cannot map m6A because Watson-Crick base
pairing is not affected by the methyl group during cDNA
conversion, thus causing the information about the base
modification to be erased in that step. Recently, a combin-
ation of immunoprecipitation and next-generation sequen-
cing enabled a localization of m6A in mRNAs within ~100
nucleotide long transcriptome regions [7,9,10].
We have previously shown that DNA base modifica-
tions can be detected by their effect on the kinetics of
DNA polymerase during SMRT DNA sequencing [11].
To test the potential of detecting RNA base modifica-
tions using the SMRT reverse transcription assay, we
used the above-described assay to compare a synthetic
RNA template containing m6A and an unmodified con-
trol template of the same sequence (Figure 2). In the
representative SMRT reverse transcription time traces
from synthetic m6A-containing and control RNA tem-
plates, the frequency of fluorescence pulses at the m6A
position was decreased compared to the native A
(Figure 2a, b), indicating that phospholinked nucleotide
binding is affected by m6A in the RNA template. A com-
parison of the distribution of interpulse durations (IPDs)
Figure 2 Detection of modified RNA bases through the kinetics of SMRT reverse transcription. (a-b) Sequences and example traces of a SMRT
reverse transcription trace on m6A-containing and unmodified A-containing control template, respectively. Enlarged trace regions show reverse
transcription signal for the underlined sequences. (c-d) Distributions of (c) interpulse durations (IPDs) and (d) pulse widths (PWs) for
phospholinked T incorporations across m6A (orange) and A (blue). The insets in (c) and (d) show histograms of the experimental counts used to
determine the cumulative distributions. Phospholinked T binding (kb) and dissociation (kd) rates were obtained from single exponential fits to
the distributions.
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plementary phospholinked T nucleotide in the active site
of the enzyme by ~5-fold (Figure 2c). Dissociation rates
were not notably affected by the presence of m6A in the
RNA template, as similar pulse width distributions were
observed for both the m6A-containing and control tem-
plate (Figure 2d).
Next, we tested the ability to detect m6A in RNA iso-
lated from a biological sample. A plasmid containing a
known m6A motif from bovine prolactin mRNA in the
3’ UTR of a GFP gene was transfected in breast cancer
cells. Total mRNA was isolated after 24 h and subjectedto the SMRT reverse transcription assay (Figure 3). The
distribution of IPDs at the site of potential m6A modifi-
cation (position 905) obtained on native mRNA revealed
a slower binding kinetics compared to the in vitro tran-
scribed control, while the dissociation kinetics remained
unaffected (Figure 3b, and Figure 3c, respectively). In
contrast, the kinetics of phospholinked T binding at a
neighboring site in the RNA template sequence (position
903) was indistinguishable in native mRNA and the con-
trol template (insets in Figure 3b, and Figure 3c). The
observed kinetic signal is thus consistent with an m6A
modification at position 905 in the native mRNA.
Figure 3 Detection of m6A in native mRNA. (a) The section of the native mRNA containing the m6A modification sequence is shown in black
with the potential site of methylation at position 905 shown in red and unmodified A at position 903 shown in dark yellow. The
methyltransferase recognition consensus sequence is indicated in brown where R represents a purine, and H is a non-guanine base. (b) The main
plot shows IPD distribution for phospholinked T incorporations across position 905 in native mRNA (red) and the in vitro transcribed control
(blue), the Inset shows IPD distributions obtained at sequence position 903 in native mRNA (dark yellow) and the in vitro transcribed control
(blue). (c) Pulse width (PW) distributions for phospholinked T incorporations across from the consensus site for m6A modification (position 905;
data obtained with native mRNA and in vitro transcribed control shown in red and blue, respectively). Inset: PW distribution for phospholinked T
incorporations at the unmodified adenosine control at position 903 (data obtained with native mRNA and in vitro transcribed control shown in
dark yellow and blue, respectively).
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RNA secondary structure is an important modifier of
biological functions and activity such as transcription,
post-transcriptional modifications, and translation. Fur-
thermore, RNA structure rearrangement progressing in
a 3’ to 5’ direction may play important roles in biological
function. For instance, reverse transcription of the retro-
viral RNA genome or cellular retro-transposon RNA
consecutively removes RNA segments from RNA struc-
tural formation, so that the remaining, not yet reverse
transcribed RNA can refold into other structures as re-
verse transcription progresses [12,13]. Similarly, mRNA
degradation by 3’ to 5’ exonuclease or 3’ to 5’ exosome
results in consecutive removal of RNA segments from
the 3’ end, so that the remaining, not yet degraded RNA
can fold into distinct structures as the exosome moves
along the mRNA [14,15].
It has previously been shown that reverse transcription
kinetics is sensitive to RNA secondary structure [16]. To
test whether our method is sensitive to structural features
in the RNA template, we first interrogated a structurally
well-defined RNA – E. coli 16S ribosomal RNA – bySMRT reverse transcription (Figure 4a). The primer ex-
tension reaction was initiated at sequence position 121
(right inset in Figure 4a). The presence of the homo-
nucleotide stretches in section of 16S rRNA sequenced
prevented determination of the exact length of reverse
transcripts when the last aligned block corresponded to a
homonucleotide stretch. For this reason, we have merged
each homonucleotide stretch of 16S rRNA sequence into
one single homonucleotide block resulting in a collapsed
16S rRNA sequence (Additional file 1: Table S4) that was
then used in the alignment of the data. The observed
number of reads ending within each homonucleotide
block was equally distributed between the composite bases
by dividing the number of the observed reads within a
homonucleotide block by the number of the constituting
bases. The histogram of the aligned reverse transcript
lengths showed a peak at sequence position 106 which
represents the start of an extended RNA stem (Figure 4a).
Two minor peaks, at sequence positions 98 and 115, indi-
cated that the method is also sensitive to detect more sub-
tle RNA structures, in this case an RNA bulge or a short
stem, respectively. The product lengths exceeding 100 nts
Figure 4 Detection of RNA structure rearrangement during SMRT reverse transcription. (a) Histogram of reverse transcript lengths on E. coli
16S rRNA. The top axis shows 16S rRNA sequence position as defined by EcoCyc [17]. The left inset shows a schematic of 16S rRNA secondary
structure. A section of 16S rRNA (gray rectangle) is expanded in the right inset, showing the start of SMRT reverse transcription and the 5’-end of
16S rRNA. Reverse transcribed bases are shown as solid blue circles and bases involved in secondary structures in transparent blue circles. Peaks
in the histogram and their corresponding 16S rRNA sequence positions are indicated by arrows. (b) Histogram of reverse transcript lengths on
human ribosomal protein S17 mRNA. Inset: Pausing probabilities along the mRNA template (blue bars), compared to calculated base-pairing
probabilities of this mRNA template using models that do not allow (red) or do allow (black) for refolding of the RNA template remaining at each
position in the DNA synthesis (Kinetic Trap Model and Equilibrium Model, respectively). A pause along mRNA template during SMRT reverse
transcription was defined as stalling of reverse transcription for longer than 5 min (Methods).
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structure of the 16S rRNA. The secondary structure in-
creases the probability of long pauses or termination
events [16]. Consequently, each base-paired template pos-
ition decreases the probability of HIV RT to extend the
nascent strand and to translocate. A succession of
basepaired positions will thus gradually decrease the num-
ber of longer product lengths until the position beyond
which undetectable number of HIV RTs will progress.
Unlike ribosomal RNA, the majority of RNAs lack a
single stable RNA fold. Instead, at equilibrium, RNA
molecules with the same sequence adopt folds with dif-
ferent basepairing combinations. This means that the
same nucleotide in an RNA sequence can be basepaired
in one fraction of these folds while it is not basepaired
in the remainder. As shown previously by Kim et al.
[18], the basepairing state of the base will determine the
average rate of nucleotide incorporation during reverse
transcription at that position. In case of a basepaired nu-
cleotide, the incorporation of the complementary nu-
cleotide in the nascent DNA strand will be more likely
to induce HIV RT pausing or termination [16,19]. Con-
sequently, the probability to observe a pausing or ter-
mination event at a particular sequence position of RNA
will depend on the fraction of molecules where this se-
quence position is in a basepaired state.
In order to test whether SMRT reverse transcription
would provide structural information on RNAs lacking a
single stable fold, we transcribed mRNA of human 40S
ribosomal protein S17 in vitro (Additional file 1: Table
S1) and performed the SMRT reverse transcription assay.The resulting histogram of aligned reverse transcript
lengths displayed a pattern with several peaks (Figure 4b).
To test whether the observed peaks correlate with RNA se-
quence positions prone to form base-paired secondary
structures, we compared the normalized experimental
pausing data to calculated base-pairing probabilities using
Kinetic trap model (Inset in Figure 4b; blue bars, and red
line, respectively, Methods). We observed good correlation
of the data with the predicted degree of secondary structure
for reverse transcripts shorter than 75 nucleotides in length,
as judged by Spearman correlation analysis (Additional file
1: Figure S5). However, this analysis failed to predict the
presence of a strong pause site observed experimentally at
position 86 (black arrows in Figure 4b). As reverse tran-
scription converts the RNA template into a DNA/RNA hy-
brid, the initial secondary structures in the RNA template
are progressively removed. We therefore hypothesized that
during the course of DNA synthesis, the remaining RNA
template may refold, rearranging RNA secondary structure
and consequently altering basepairing probabilities [18].
We thus calculated basepairing probabilities using a model
where the structure of the yet untranscribed RNA template
was allowed to re-equilibrate prior to nucleotide incorpor-
ation (Equilibrium model in Methods). The basepairing
probabilities calculated using this model (Inset in Figure 4b,
black line, Additional file 1: Figure S6) captured the later
pausing behavior observed in SMRT reverse transcription
assay, demonstrating that SMRT reverse transcription not
only allows the detection of relatively static, stable RNA
structures, but may also allow the real-time interrogation of
structural rearrangements in RNA.
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In contrast to SMRT DNA sequencing, the SMRT re-
verse transcription assay utilizing HIV-RT produces
multiple binding events for each nucleotide incorpor-
ation and relatively short read-lengths. This is not sur-
prising since this enzyme has not yet been optimized for
incorporation of phospholinked nucleotides, and is rem-
iniscent to the performance of the SMRT DNA sequen-
cing at the starting point. We are in the process of
engineering RTs to obtain a mode where each nucleotide
binding event results in a successful incorporation,
through changes in the enzyme analogous to our previ-
ous DNA polymerase engineering [3]. In addition, the
observed read-lengths (Figure 4b) are shorter than previ-
ously reported in vitro processivities of HIV RT [20]. This
is due to the use of nucleotide analogues in place of the
native nucleotides. Our bulk studies suggest that the ability
of HIV RT to progress through RNA template is hampered
by the bulky nature of the fluorescence probes attached
to the nucleotide analogues (data not shown). Read-
lengths can be improved by increasing the RT’s processivity
in the presence of nucleotide analogues through mutations,
or by employing viral RNA-dependent RNA polymerases
(RdRPs) that exhibit extremely high processivities on
RNA templates [21]. For example, we have evaluated a
member of this class of enzymes, φ6 RdRP, and found that
it can utilize phospholinked nucleotides (Additional file 1:
Figure S7).
In summary, we have demonstrated the ability to ob-
serve reverse transcription using SMRT technology,
allowing information about sequence content, base mod-
ifications, and structural rearrangement of RNA to be
obtained simultaneously. We were able to detect m6A
modifications in a specific mRNA from a mixture of
total cellular mRNA, and to identify structural rear-
rangements in an mRNA. We anticipate that the appli-
cation of our method may enable the identification of
the location of many modified bases in mRNA and pro-
vide detailed information about the nature and the dy-
namic RNA refolding in retroviral/retro-transposon




Methods for expression and purification of HIV reverse
transcriptase (HIV RT) were adapted from previously
published procedures [22,23]. E. coli expression vectors
for HIV RT p66 and His-tagged p51 subunits were cus-
tom synthesized by DNA 2.0 (Menlo Park, CA). BL21 E.
coli were transformed with each expression vector and
cultured overnight. After 100-fold dilution into fresh LB
media, the cultures were grown further at 37°C. The in-
cubator temperature was reduced to 18°C when the E.coli density reached 0.9 OD600 followed by the addition
of 1 mM IPTG for induction. The cultures were allowed
to grow overnight before harvesting.
Cell pellets from the p66 and p51 cultures were com-
bined in 2:1 weight ratio and re-suspended in lysis buffer
(30 mM HEPES pH 7.5, 60 mM NaCl, 2 mM EDTA, 1
mM DTT, and 1mM PMSF). The cell suspension was
passed through a microfluidizer device 3 times at 80 psi
(Microfluidics, Newton, MA) to lyse the cells. HIV RT
was released from bacterial DNA by adding 0.5 M NaCl
to the lysate and stirring for 30 min at 4°C. PEI was then
slowly added to the stirring lysate to 0.3% final concen-
tration and stirred for another 30min. Precipitated bac-
terial DNA was removed by centrifugation. Ammonium
sulfate was added at 0.37 g/ml to the cleared lysate and
precipitated proteins were collected by centrifugation.
Protein pellets were re-suspended with 30 mM HEPES
pH 7.5 and buffer content adjusted to Buffer A (30 mM
HEPES pH 7.5, 500 mM NaCl, and 10 mM imidazole).
The HIV-RT was then purified using a HisTrap FF crude
column (GE Healthcare, USA) and a 10 mM to 500 mM
imidazole linear gradient. Collected fractions containing
HIV-RT heterodimer were pooled and concentrated
using a 30k MWCO Vivaspin 4 device (Sartorius Stedim
Biotech, France). A Superdex 200 column was used for
the final purification step. Purified HIV RT was stored
at −20°C in a buffer containing 47.5% glycerol, 30 mM
HEPES pH 7.5, 60 mM NaCl, 0.1 mM EDTA, and 1 mM
DTT. The final concentration was determined by UV
absorbance and extinction coefficients calculated from
the amino acid sequences.
Nucleic acid preparation
All nucleic acids used in the study are listed in Additional
file 1: Tables S1 and Additional file 1: S2. All DNA primers
as well as synthetic RNA and ssRNA templates were
ordered from IDT and dissolved in 1x TE.
m6A and m6A control templates were synthesized as
described previously [24]. DNA sequence for native
mRNA was designed to contain the 3’-UTR sequ-
ence from bovine prolactin mRNA (NCBI Reference
Sequence: NM_173953.2), followed by an adaptor
(5’-GCGCGCTATAGATATAAAAAGTGG). This DNA
sequence was cloned into the pEGFP-C1 plasmid
(Clontech), between XhoI and BamHI sites. The plasmid
was then transfected into MDA-MB-231 cells (~85-90%
confluent) with Lipofectamine 2000 (Invitrogen), follow-
ing the procedure suggested by the manufacturer. GFP
level was monitored after 24 h of transfection to insure
the expression of GFP protein, and thus the production
of the designed native mRNA. polyA+ RNA was subse-
quently isolated with FastTrack 2.0 mRNA isolation kit
(Invitogen). Control for the native mRNA was obtained
through in vitro run-off transcription using T7 RNA
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plasmid used in the transfection.
Ribosomal RNA from E. coli was purchased from Ap-
plied Biosystems as solution of total RNA from E. coli.
mRNA template was synthesized by in vitro run-off
transcription using cDNA of 216 nt long 3’-end section
of the human 40S ribosomal protein S17 gene and T7
promoter, as described previously [23].
Nucleic acid hybridization
All complementary nucleic acids were hybridized in 10
mM Tris, pH 7.5, 75 mM KCl and incubated at 65°C for
5 min followed by gradual cooling to 25°C at 0.1°C s-1
and cooled down to 4°C before storing at −20°C. All
hybridization pairs used in this study are listed in
Additional file 1: Tables S1 and Additional file 1: S2.
Activity of reverse transcriptases (RT) in the presence of
phospholinked nucleotides
We have tested in-house HIV RT and commercially
available AMV RT (New England Biolabs, MA), and
MMLV RT (New England Biolabs, MA) for their ability
to incorporate phospholinked nucleotides. To this pur-
pose, we have hybridized synthetic RNA template and
FAM-P5 DNA primer (Additional file 1: Table S1) as de-
scribed above.
For each reverse transcriptase tested, reaction mix-
tures with native and phospholinked nucleotides were
prepared separately. Each mixture was prepared in du-
plicates and contained 2 μM DNA-primed synthetic
RNA template, 3 μM per nucleotide, 100 units/mL
reverse transcriptase, and 1x RT buffer. In the case of
HIV RT, the reaction buffer described below was used
while recommended manufacturer reaction buffers
were used for AMV and MMLV RTs. One of the mix-
ture duplicates was supplemented with 45 mM EDTA
for a negative control. All mixtures were incubated at
37°C for 1 h. The reverse transcriptions were then
stopped with 45 mM EDTA, mixed with 2x volume
of RNA Sample Loading Buffer (Sigma-Aldrich), and
denatured for 10 min at 65°C. Denatured samples
were run on a denaturing 15% PAGE, and analyzed
on a Typhoon imager (GE Healthcare Life Sciences).
Single nucleotide incorporation rates in reverse
transcription
We have determined nucleotide binding rates k1, nucleo-
tide dissociation rates k−1, and incorporation rates (k2)
for phospholinked nucleotides using pre-steady state
bulk kinetic assays (Additional file 1: Scheme S1).
First, we determined binding and incorporation rates
for each phospholinked nucleotide in a real-time
stopped-flow experiment. DNA templates labeled with
6-carboxyfluorescein (FAM) at their 5’-ends were firsthybridized to their corresponding DNA primer (Additional
file 1: Table S2). Measurements were carried out in SMRT
reverse transcription reaction buffer (50 mM Tris pH 8.3 at
room temperature, 10 mM KCl, 0.05 mM CaCl2, 5 mM
DDT, 0.2 units· μl-1 Superase•In™, 2 vol% FMP, 5 mM
Trolox, 2 mM PCA, 1x PCD, 2.5 mM MgCl2). Changes
in FAM fluorescence upon mixing of the nucleotide
analog with RT-DNA template complex were recorded with
a SF-2004 stopped-flow instrument (Kintek, Austin, TX).
k−1 and k2 were determined by nonlinear regression ei-
ther by the stopped-flow software or by the KaleidaGraph
software using double-exponential and hyperbolic
equations with data collected at various nucleotide
concentrations.
To measure the dissociation rate of phospholinked nu-
cleotides (k−1 in Additional file 1: S1), we hybridized the
above DNA templates to dideoxynucleotide-terminated
DNA primers (Additional file 1: S2). Ternary complexes of
RT, phospholinked fluorescent nucleotides, and DNA
template were prepared for a stopped-flow assay. The
fluorescence signal was recorded as described above. Sub-
sequently, k−1 was determined from the increase in fluor-
escence signal upon addition of unlabeled nucleotides.
RNA replication with RNA-dependent RNA polymerase
from Bacteriophage ϕ6 using phospholinked nucleotides
Stalling and replication was carried out as previously
described by Dekker and coworkers [25]. Briefly, ssRNA
template (Additional file 1: S1) was used as a template in
the replication reaction. RNA-dependent RNA polymer-
ase from Bacteriophage φ6 (φ6 RdRP) was first stalled
on ssRNA in the presence of three ribonucleotides
(rATP, rGTP, and rUTP), and reinitiated by the addition
of native rCTP or phospholinked rCTP. Reinitiated rep-
lication was carried out at 32°C for 4 h. Reaction prod-
ucts were analyzed on a native PAGE.
SMRT reverse transcription assay
Phospholinked dNTPs were generated as described previ-
ously [3,26]. ZMW nanostructures were fabricated and
functionalized as previously described [18,27]. Single-
molecule experiments were performed using arrays of
3,000 ZMWs monitored simultaneously, with excitation
laser lines as described previously [3,28]. 5’-biotinylated
DNA primer was hybridized to RNA template and incu-
bated with streptavidin at 1:1 molar ratio in Immobilization
Buffer (50 mM Tris pH 8.0, 10 mM KCl, 0.1 mM CaCl2, 5
mM DDT, 0.2 units·μl-1 Superase•In™ (Applied Biosystems,
Carlsbad, CA)) at 37°C for 5 min and stored on ice. DNA
primer-RNA template-streptavidin complex was immo-
bilized in ZMWs by incubation on ZMW arrays for 5 min
at room temperature in the Immobilization Buffer. Excess
complex was removed by washing with Wash Buffer (50
mM Tris pH 8.3 at room temperature, 10 mM KCl, 0.05
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-1 Superase•In™, 2.5
mM MgCl2). Next, 30 μl Reaction Buffer (50 mM Tris pH
8.3 at room temperature, 10 mM KCl, 0.05 mM CaCl2, 5
mM DDT, 0.2 units· μl-1 Superase•In™, 2 vol% FMP, 5 mM
Trolox, 2 mM PCA, 1x PCD, 2.5 mM MgCl2, and 3 μM of
each phospholinked nucleotide) was applied to the array
and placed in the instrument. The recording of the fluores-
cent signals was started and reverse transcription on the
chip was initiated by adding 10 μl of Enzyme Buffer (Reac-
tion Buffer supplemented with 2 nM HIV RT) at room
temperature. The movie acquisition was stopped after 15
min. In the case of experiments carried out at 37°C, the
above Reaction Buffer was replaced by Reaction Buffer 2
(50 mM Tris pH 8.5 at room temperature, 10 mM KCl,
0.05 mM CaCl2, 5 mM DDT, 0.2 units· μl
-1 Superase•In™, 2
vol% FMP, 5 mM TSQ, 5.8 mM PCA, 1x PCD, 60 μg· ml-1
BSA, 2.5 mM MgCl2, 3 μM per nucleotide analogue; ionic
strength at 37°C approx. 35 mM). In addition, when the
experiments were carried out at 37°C, the fluorescent signal
was measured in 10 successive 5 min long movies with
ZMW array alignment steps after each movie to correct for
thermal drift.
Data collection and analysis
Data were collected on a highly parallel confocal
fluorescence detection instrument, as previously de-
scribed [3,28]. Pulse calling, which uses a threshold
algorithm of the dye-weighted intensities of fluores-
cence emissions, has been described previously [3].
The links to the raw data are listed in Additional file
1: Table S5.
HIV RT pausing during SMRT reverse transcription
A pause along mRNA template during SMRT reverse
transcription was defined as stalling of reverse transcrip-
tion for longer than 5 min. The pausing probability for a
given sequence position was then defined as a fraction
of reverse transcription events pausing at that position
relative to the total number of reverse transcripts
containing this position.
Basepairing probability on mRNA and SMRT reverse
transcription pausing
We have applied two different models to calculate the
basepairing probability for each sequence position of
mRNA template when it is present in the active site of
HIV RT. In the Kinetic Trap Model (KTM), an ensemble
of full length mRNA folds was first generated using the
program mfold [29] with the following conditions:
folding temperature 37°C, suboptimality 33%, window
parameter 1, and preventing basepairing of nucleotides
hybridized to DNA primer (bolded nucleotides in
Additional file 1: Table S1). Next, the resulting ensemble
folds were used to calculate basepairing probabilitiesfor every nucleotide of mRNA during the first nucleo-
tide incorporation event:








where Pbp(1,j) is the basepairing probability for j-th nu-
cleotide when the first nucleotide is bound in the RT ac-
tive site, n is the number of mfold structures where j-th
nucleotide is in a basepaired state, m is the number of all
calculated mfold structures, ΔGk is a free energy of folding
a k structure, ΔGl is a free energy of folding an l structure,
R is the gas constant (8.314 J·(mol·K)-1), and T is reaction
temperature (310.15 K). After the first nucleotide incorp-
oration, RT translocates to the second nucleotide. The
base pairs of the initial ensemble of mRNA folds are
retained except for those involving the first base that has
been reverse transcribed and is now forming part of
the RNA/cDNA hybrid product. A set of basepairing
probabilities Pbp(2,j) was then determined using the
readjusted ensemble of mRNA folds. This procedure
was subsequently repeated for every mRNA sequence
position. The calculated basepairing probabilities were
corrected since the stability of a predicted base pair
can depend on the basepairing state of its sequence
neighbors [30]. We have thus calculated an average
basepairing probability for each nucleotide when present in
the active site of RT by averaging the above basepairing
probabilities with a sliding window upstream of the nucleo-
tide in the active site:
P
0
bp j; jð Þ ¼
Xjþw
i¼j Pbp j; ið Þ
w
where Pbp’(j,j) is the average basepairing probability for
j-th nucleotide when it is bound in the active site of
HIV RT, and w+1 is the width of the sliding window.
We have calculated Pbp’(j,j) values using w values of 0, 2,
4, 6, and 8 (Additional file 1: Figure S5a-e). The correl-
ation between Pbp’(j,j) values and experimentally mea-
sured pausing probability on mRNA was evaluated using
the Spearman correlation coefficient (Additional file 1:
Figure S4f ). The coefficient increased from w = 0 to w =
4, where it plateaued above the critical value (0.38 at
99.9% confidence level and 73 degrees of freedom; green
dashed line in Additional file 1: Figure S4f ). Averaging
beyond w = 4 did not improve the correlation coeffi-
cient notably.
In the Equilibrium Model (EM), the initial ensemble of
mRNA folds and the basepairing probabilities were de-
termined in the same way as described above for KTM.
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translocation to the second base, the untranscribed
mRNA now shortened by one nucleotide was allowed to
re-equilibrate to a new ensemble of stable folds. A set of
basepairing probabilities Pbp(2,j) was then obtained using
the re-equilibrated ensemble of mRNA folds. This re-
equilibration procedure was subsequently repeated for
every mRNA sequence position, and basepairing probabil-
ities averaged as explained above for KTM using w = 4
(Additional file 1: Figure S5).
Additional file
Additional file 1: Scheme S1. Reaction mechanism of reverse
transcriptase. Figure S1. Activity of HIV, AMV and MMLV reverse
transcriptases (RTs) in the presence of phospholinked nucleotides (PL-Ns).
Figure S2 (a)-(j). Examples of SMRT reverse transcription traces obtained
with synthetic RNA template. Figure S3. Determination of binding,
dissociation and incorporation rates for HIV RT using phospholinked
nucleotides. Figure S4. Cumulative distributions of block widths during
SMRT reverse transcription for incorporations of A (yellow), C (red), G
(green), and T (blue) phospholinked nucleotides by HIV RT in ZMWs.
Figure S5. Basepairing probabilities on mRNA template calculated using
the Kinetic Trap Model (KTM). Figure S6. Basepairing probabilities on
mRNA calculated using the Equilibrium Model (EM). Figure S7. Activity of
RNA-dependent RNA polymerase from bacteriophage φ6 (φ6 RdRP) in
the presence of a phospholinked rCTP. Table S1. RNA templates and
DNA primers used in SMRT reverse transcription. Table S2. Sequences of
DNA templates and corresponding DNA primers used in the bulk
measurements of HIV RT transcription kinetics (Additional file 1: Figure
S1). Table S3. Bulk kinetics data obtained with stopped-flow experiments
(Additional file 1: Figure S1) for all four phospholinked nucleotides used
in SMRT reverse transcription. Table S4. Collapsed sequences of 16S
rRNA and mRNA. Table S5. A list links to the raw data.
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